All listed companies
Nomu Parallel MarketHealthcare

Professional Medical Expertise Inc. 9574

Medical Devices

78.40 SAR

-2.43% · close 2026-11-12

Price history (daily closes)

130 closes · -18.46% over period

Previous close

80.35 SAR

Volume

5.23K

52-week high

107.00 SAR

52-week low

78.10 SAR

Market cap

281.57M SAR

P/E (trailing)

6.4

EPS (TTM)

12.56

Dividend yield

—

About Professional Medical Expertise Inc.

Professional Medical Expertise Inc. operates as a leading provider of healthcare services specializing in comprehensive medical consultations and diagnostics. Its primary function is to offer expert medical opinions and advanced diagnostic solutions to enhance patient care and treatment efficacy. The company plays a crucial role in the healthcare sector, leveraging state-of-the-art technology to ensure accurate diagnostics and personalized medical advice. With a focus on quality and innovation, Professional Medical Expertise Inc. impacts both individual patients and broader healthcare systems by collaborating with hospitals, clinics, and independent medical practitioners. Its services are pivotal in areas such as chronic disease management, preventive healthcare, and telemedicine, reflecting its commitment to accessibility and efficiency in medical care delivery. As part of its market significance, the company contributes to reducing diagnostic errors and improving patient outcomes, thereby playing a transformative role in the modern healthcare landscape.

Ticker
9574
Board
Nomu
Currency
SAR
Shares outstanding
3.50M
First seen in list
2026-10-08
Website
Visit

Trading this stock

Nomu shares can only be bought by Qualified Investors under CMA rules. Your broker must support the Parallel Market and you must meet the eligibility test.

Brokers that give you access

All brokers

Other Healthcare companies

Prices are end-of-day closes from the Saudi Exchange via Twelve Data, retrieved 2026-11-15 05:39 UTC. Fundamentals and the company profile come from the same provider (statistics as of 2026-11-07) and may lag filings. Nothing on this page is investment advice or a recommendation to buy or sell.

We use cookies to run the site and show relevant offers. Cookie Policy.